{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:27:53Z","timestamp":1789194473018,"version":"build-2803163510"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"am","delay-in-days":336,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.diabres.2024.111983","type":"journal-article","created":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T17:22:34Z","timestamp":1735665754000},"page":"111983","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Managing obesity in adults with type 1 diabetes"],"prefix":"10.1016","volume":"220","author":[{"given":"Alejandro","family":"Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene Rivera","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo J.","family":"Galindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rozalina G.","family":"McCoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Hurtado Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.7326\/M22-3078","article-title":"Prevalence and management of obesity in U.S. adults with type 1 diabetes","volume":"176","author":"Fang","year":"2023","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.5604\/12321966.1141381","article-title":"Gender and Age - dependent effect of type 1 diabetes on obesity and altered body composition in young adults","volume":"22","author":"Szadkowska","year":"2015","journal-title":"Ann Agric Environ Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","article-title":"Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study","volume":"15","author":"Rogers","year":"2017","journal-title":"BMC Med"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes-early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2024.111983_b0025","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001-2017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.diabres.2024.111983_b0030","unstructured":"Fryar CD, Carroll MD, Afful J. Prevalence of Overweight, Obesity, and Severe Obesity Among Adults Aged 20 and Over: United States, 1960\u20131962 Through 2017\u20132018 2020 [updated 2\/8\/2021. Available from: https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-adult-17-18\/overweight-obesity-adults-H.pdf."},{"issue":"3\u20134","key":"10.1016\/j.diabres.2024.111983_b0035","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00508-018-1434-9","article-title":"Overweight and obesity in type 1 diabetes equal those of the general population","volume":"131","author":"Fellinger","year":"2019","journal-title":"Wien Klin Wochenschr"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"Purnell","year":"2013","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0045","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1210\/clinem\/dgab927","article-title":"Obesity and chronic kidney disease in US adults with type 1 and type 2 diabetes mellitus","volume":"107","author":"Wallace","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jdiacomp.2016.10.006","article-title":"Obstructive sleep apnoea is frequent in patients with type 1 diabetes","volume":"31","author":"Banghoej","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.diabres.2024.111983_b0055","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1031633","article-title":"Non-alcoholic fatty liver disease in type 1 diabetes: Prevalence and pathophysiology","volume":"13","author":"Memaj","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0060","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14376","article-title":"Metabolic syndrome in type 1 diabetes and its association with diabetes complications","volume":"38","author":"Lee","year":"2021","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0065","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jdiacomp.2015.03.014","article-title":"Prevalence and clinical profile of metabolic syndrome among type 1 diabetes mellitus patients in southern India","volume":"29","author":"Billow","year":"2015","journal-title":"J Diabetes Compl"},{"issue":"6","key":"10.1016\/j.diabres.2024.111983_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2023.102781","article-title":"Metabolic syndrome in patients with type 1 diabetes mellitus at a tertiary centre in North India: A five year follow up study","volume":"17","author":"Agrawal","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0075","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/dia.2023.0389","article-title":"Weight gain and glycemic control in adults with type 1 diabetes in the T1D exchange registry","volume":"26","author":"Bailey","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"11","key":"10.1016\/j.diabres.2024.111983_b0080","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","article-title":"Obesity in people living with type 1 diabetes","volume":"9","author":"Van der Schueren","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.diabres.2024.111983_b0085","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00125-022-05722-5","article-title":"Obesity in late adolescence and incident type 1 diabetes in young adulthood","volume":"65","author":"Zucker","year":"2022","journal-title":"Diabetologia"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0090","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1399-5448.2011.00831.x","article-title":"The convergence of type 1 and type 2 diabetes in childhood: the accelerator hypothesis","volume":"13","author":"Wilkin","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/j.diabres.2024.111983_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0100","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.soard.2022.08.013","article-title":"2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and international federation for the surgery of obesity and metabolic disorders (IFSO): indications for metabolic and bariatric surgery","volume":"18","author":"Eisenberg","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.diabres.2024.111983_b0105","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the american college of cardiology\/american heart association task force on practice guidelines and the obesity society","author":"Jensen","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2024.111983_b0110","series-title":"Total dietary regulation in the treatment of diabetes","author":"Allen","year":"1919"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-5996-4-23","article-title":"Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: a clinical audit","volume":"4","author":"Nielsen","year":"2012","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/ajcn\/63.1.110","article-title":"Effects of diet composition and ketosis on glycemia during very-low-energy-diet therapy in obese patients with non-insulin-dependent diabetes mellitus","volume":"63","author":"Gumbiner","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabres.2024.111983_b0125","doi-asserted-by":"crossref","DOI":"10.1111\/dme.13663","article-title":"The glycaemic benefits of a very-low-carbohydrate ketogenic diet in adults with Type 1 diabetes mellitus may be opposed by increased hypoglycaemia risk and dyslipidaemia","author":"Leow","year":"2018","journal-title":"Diabet Med"},{"issue":"10","key":"10.1016\/j.diabres.2024.111983_b0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3949\/ccjm.88a.20121","article-title":"Ketogenic diets in the management of type 1 diabetes: Safe or safety concern?","volume":"88","author":"Buehler","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.diabres.2024.111983_b0135","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.freeradbiomed.2016.03.020","article-title":"Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes","volume":"95","author":"Kanikarla-Marie","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"16","key":"10.1016\/j.diabres.2024.111983_b0140","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.3390\/nu15163525","article-title":"Efficacy of fasting in type 1 and type 2 diabetes mellitus: a narrative review","volume":"15","author":"Herz","year":"2023","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0145","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1464-5491.2007.02098.x","article-title":"Type 1 diabetes and prolonged fasting","volume":"24","author":"Reiter","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabres.2024.111983_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00849","article-title":"Intermittent fasting could be safely achieved in people with type 1 diabetes undergoing structured education and advanced glucose monitoring","volume":"10","author":"Al-Ozairi","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2024.111983_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.656346","article-title":"Impact of a single 36 hours prolonged fasting period in adults with type 1 diabetes \u2013 a cross-over controlled trial","volume":"12","author":"Moser","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.diabres.2024.111983_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108626","article-title":"Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey","volume":"172","author":"Hassanein","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0165","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/dom.14911","article-title":"Weight management in young adults with type 1 diabetes: the advancing Care for type 1 diabetes and obesity Network sequential multiple assignment randomized trial pilot results","volume":"25","author":"Igudesman","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2024.111983_b0170","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13256","article-title":"Effect of exercise training on weight loss, body composition changes, and weight maintenance in adults with overweight or obesity: An overview of 12 systematic reviews and 149 studies","volume":"22","author":"Bellicha","year":"2021","journal-title":"Obes Rev"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0175","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41574-022-00756-6","article-title":"Exercise in adults with type 1 diabetes mellitus","volume":"19","author":"Riddell","year":"2023","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0180","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00125-020-05263-9","volume":"63","author":"Moser","year":"2020","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0185","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2337\/dsi22-0018","article-title":"Practical aspects and exercise safety benefits of automated insulin delivery systems in type 1 diabetes","volume":"36","author":"Zaharieva","year":"2023","journal-title":"Diabetes Spectrum"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0190","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0195","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.diabres.2014.09.038","article-title":"A systematic review and meta-analysis of exercise interventions in adults with type 1 diabetes","volume":"106","author":"Yardley","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.diabres.2024.111983_b0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1037\/amp0000293","article-title":"Behavioral interventions for obesity in children and adults: Evidence base, novel approaches, and translation into practice","volume":"73","author":"Wilfley","year":"2018","journal-title":"Am Psychol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0205","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jdiacomp.2015.09.003","article-title":"Fear of hypoglycemia in adults with type 1 diabetes: impact of therapeutic advances and strategies for prevention - a review","volume":"30","author":"Martyn-Nemeth","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0210","doi-asserted-by":"crossref","DOI":"10.7748\/ns.29.2.44.e7877","article-title":"Diabulimia: how eating disorders can affect adolescents with diabetes","volume":"29","author":"Davidson","year":"2014","journal-title":"Nurs Stand"},{"key":"10.1016\/j.diabres.2024.111983_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109783","article-title":"Caring for individuals with Type 1 Diabetes Mellitus who restrict and omit insulin for weight control: Evidence-based guidance for healthcare professionals","volume":"185","author":"Goddard","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.diabres.2024.111983_b0220","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.2337\/dc17-0403","article-title":"Use of adjuvant pharmacotherapy in type 1 diabetes: international comparison of 49,996 individuals in the prospective diabetes follow-up and T1D exchange registries","volume":"40","author":"Lyons","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2024.111983_b0225","doi-asserted-by":"crossref","unstructured":"Effect of intensive diabetes management on macrovascular events and risk factors in the diabetes control and complications trial. The American Journal of Cardiology. 1995;75(14):894-903.","DOI":"10.1016\/S0002-9149(99)80683-3"},{"issue":"10","key":"10.1016\/j.diabres.2024.111983_b0230","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.numecd.2019.06.008","article-title":"Long-term body weight trajectories and metabolic control in type 1 diabetes patients on insulin pump or multiple daily injections: A 10-year retrospective controlled study","volume":"29","author":"Alderisio","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13300-019-00743-7","article-title":"Insulin therapy in adults with type 1 diabetes mellitus: a narrative review","volume":"11","author":"Jane\u017e","year":"2020","journal-title":"Diabetes Therapy"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4158\/EP.11.1.11","article-title":"Optimized basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with basal insulin glargine","volume":"11","author":"Garg","year":"2005","journal-title":"Endocr Pract"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0245","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12609","article-title":"Use of medications associated with weight change among participants in the All of Us research programme","volume":"13","author":"Almazan","year":"2023","journal-title":"Clin Obes"},{"key":"10.1016\/j.diabres.2024.111983_b0250","unstructured":"Rueda-Clausen CF PM, Lear SA, Poirier P, Sharma AM. Canadian Adult Obesity Clinical Practice Guidelines: Assessment of People Living with Obesity. obesitycanada.ca\/guidelines.2020 [cited 2023 July 5]. Available from: obesitycanada.ca\/guidelines."},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0255","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1742-7843.2009.00380.x","article-title":"The effect of metformin in overweight patients with type 1 diabetes and poor metabolic control","volume":"105","author":"Jacobsen","year":"2009","journal-title":"Basic Clin Paharmacol Toxicol"},{"issue":"8","key":"10.1016\/j.diabres.2024.111983_b0260","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0265","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1089\/dia.2014.0190","article-title":"Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysis","volume":"17","author":"Liu","year":"2014","journal-title":"Diabetes Technol Ther"},{"issue":"10","key":"10.1016\/j.diabres.2024.111983_b0270","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.2337\/dc06-0042","article-title":"A double-blind, placebo-controlled trial assessing pramlintide treatment in the setting of intensive insulin therapy in type 1 diabetes","volume":"29","author":"Edelman","year":"2006","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2024.111983_b0275","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1111\/j.1464-5491.2004.01319.x","article-title":"Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial","volume":"21","author":"Ratner","year":"2004","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pcd.2023.10.010","article-title":"Sodium glucose cotransporter2 inhibitors for type 1 diabetes mellitus: a meta-analysis of randomized controlled trials","volume":"18","author":"Nan","year":"2024","journal-title":"Prim Care Diabetes"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003461","article-title":"Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression","volume":"17","author":"Musso","year":"2020","journal-title":"PLoS Med"},{"issue":"6","key":"10.1016\/j.diabres.2024.111983_b0290","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2337\/dc18-2316","article-title":"International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium\u2013glucose cotransporter (SGLT) inhibitors","volume":"42","author":"Danne","year":"2019","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0295","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(15)00436-2","article-title":"Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Dejgaard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0300","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/dom.13911","article-title":"Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin\u2010pump\u2010treated patients with type 1 diabetes: The Lira Pump trial\u2014a randomized, double\u2010blinded, placebo\u2010controlled trial","volume":"22","author":"Dejgaard","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2024.111983_b0305","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad471","article-title":"Glucagon-like peptide 1 Analogues as Adjunctive Therapy for Patients with Type 1 Diabetes: an Updated Systematic Review and Meta-analysis","author":"Park","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0310","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1210\/clinem\/dgac618","article-title":"Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study","volume":"108","author":"Edwards","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0315","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabres.2024.111983_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","author":"Garvey","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.diabres.2024.111983_b0325","first-page":"1","article-title":"Effect of tirzepatide on body weight and diabetes control in adults with type 1 diabetes and overweight or obesity","author":"Rivera Gutierrez","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.diabres.2024.111983_b0330","doi-asserted-by":"crossref","DOI":"10.1007\/s13300-024-01592-9","article-title":"Changes in basal and bolus insulin requirements with tirzepatide as an adjunctive therapy in adults with type 1 diabetes using tandem control-IQ","author":"Karakus","year":"2024","journal-title":"Diabetes Ther"},{"issue":"6","key":"10.1016\/j.diabres.2024.111983_b0335","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/dia.2024.0050","article-title":"Efficacy and safety of tirzepatide in overweight and obese adult patients with type 1 diabetes","volume":"26","author":"Garg","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0340","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.aace.2023.04.010","article-title":"Diabetic ketoacidosis in a patient with type i diabetes treated with a closed-loop sensor-augmented insulin infusion system","volume":"9","author":"Sharma","year":"2023","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.diabres.2024.111983_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102782","article-title":"GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review","volume":"75","author":"Alfaris","year":"2024","journal-title":"eClinicalMedicine"},{"issue":"11","key":"10.1016\/j.diabres.2024.111983_b0350","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0355","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(17)30285-6","article-title":"Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial","volume":"2","author":"Halawi","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.diabres.2024.111983_b0360","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"10.1016\/j.diabres.2024.111983_b0365","doi-asserted-by":"crossref","first-page":"S335","DOI":"10.1016\/j.jval.2022.04.254","article-title":"EE2 A cost-effectiveness analysis comparing obesity drug treatments from a US payer perspective","volume":"25","author":"G\u00f3mez-Lumbreras","year":"2022","journal-title":"Value Health"},{"issue":"24","key":"10.1016\/j.diabres.2024.111983_b0370","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.diabres.2024.111983_b0375","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1210\/jc.2018-00070","article-title":"Semaglutide added to basal insulin in type 2 diabetes (sustain 5): a randomized, controlled trial","volume":"103","author":"Rodbard","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0380","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1089\/dia.2021.0319","article-title":"Safety and glycemic outcomes during the minimed\u2122 advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes","volume":"24","author":"Carlson","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0385","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1177\/19322968231161320","article-title":"Advanced hybrid closed loop in adult population with type 1 diabetes: a substudy from the ADAPT randomized controlled trial in users of real-time continuous glucose monitoring","volume":"18","author":"van den Heuvel","year":"2024","journal-title":"J Diabetes Sci Technol"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0390","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/SLA.0000000000003614","article-title":"Effect of sleeve gastrectomy on ghrelin, GLP-1, PYY, and GIP gut hormones: a systematic review and meta-analysis","volume":"272","author":"McCarty","year":"2020","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0395","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/j.1550-8528.1999.tb00436.x","article-title":"Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study","volume":"7","author":"Sj\u00f6str\u00f6m","year":"1999","journal-title":"Obes Res"},{"issue":"2","key":"10.1016\/j.diabres.2024.111983_b0400","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/000313481508100229","article-title":"Laparoscopic Roux-en-Y gastric bypass versus sleeve gastrectomy for obese patients with Type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"81","author":"Wang","year":"2015","journal-title":"Am Surg"},{"issue":"7","key":"10.1016\/j.diabres.2024.111983_b0405","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s11695-015-1670-2","article-title":"Revisional Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review of comparative outcomes with respective primary procedures","volume":"25","author":"Mahawar","year":"2015","journal-title":"Obes Surg"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0410","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1381\/096089292765559891","article-title":"Why does the gastric bypass control type 2 diabetes mellitus?","volume":"2","author":"Pories","year":"1992","journal-title":"Obes Surg"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0415","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.soard.2014.12.016","article-title":"Should metabolic surgery be offered in morbidly obese patients with type I diabetes?","volume":"11","author":"Robert","year":"2015","journal-title":"Surg Obes Relat Dis"},{"issue":"8","key":"10.1016\/j.diabres.2024.111983_b0420","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.2337\/dc14-0583","article-title":"Bariatric surgery induces weight loss but does not improve glycemic control in patients with type 1 diabetes","volume":"37","author":"Lannoo","year":"2014","journal-title":"Diabetes Care"},{"issue":"4","key":"10.1016\/j.diabres.2024.111983_b0425","doi-asserted-by":"crossref","first-page":"647","DOI":"10.33549\/physiolres.931995","article-title":"Gut peptide hormones and pediatric type 1 diabetes mellitus","volume":"60","author":"Huml","year":"2011","journal-title":"Physiol Res"},{"issue":"5","key":"10.1016\/j.diabres.2024.111983_b0430","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.cell.2017.01.025","article-title":"Gut-brain cross-talk in metabolic control","volume":"168","author":"Clemmensen","year":"2017","journal-title":"Cell"},{"issue":"1\u20133","key":"10.1016\/j.diabres.2024.111983_b0435","first-page":"68","article-title":"Growth hormone and diabetes mellitus","volume":"40","author":"S\u00f6nksen","year":"1993","journal-title":"Hormone Res Paediat"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.15420\/ecr.2018.33.1","article-title":"The role of inflammation in diabetes: current concepts and future perspectives","volume":"14","author":"Tsalamandris","year":"2019","journal-title":"Eur Cardiol"},{"issue":"6","key":"10.1016\/j.diabres.2024.111983_b0445","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1463-1326.2006.00686.x","article-title":"Insulin-associated weight gain in diabetes \u2013 causes, effects and coping strategies","volume":"9","author":"Russell-Jones","year":"2007","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0450","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1177\/1932296814566231","article-title":"Physical activity and type 1 diabetes: time for a rewire?","volume":"9","author":"Colberg","year":"2015","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0455","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/oby.2011.94","article-title":"Blood pressure and heart rate effects, weight loss and maintenance during long\u2010term phentermine pharmacotherapy for obesity","volume":"19","author":"Hendricks","year":"2011","journal-title":"Obesity"},{"issue":"9774","key":"10.1016\/j.diabres.2024.111983_b0460","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.diabres.2024.111983_b0465","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1001\/jama.2015.1617","article-title":"Naltrexone extended-release plus bupropion extended-release for treatment of obesity","volume":"313","author":"Yanovski","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0470","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.diabres.2024.111983_b0475","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1463-1326.2004.00428.x","article-title":"Reduction of body weight and co\u2010morbidities by orlistat: The XXL\u2013Primary Health Care Trial","volume":"7","author":"Wirth","year":"2005","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"10.1016\/j.diabres.2024.111983_b0480","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1345\/aph.1M210","article-title":"The role of pramlintide for weight loss","volume":"44","author":"Dunican","year":"2010","journal-title":"Ann Pharmacother"},{"issue":"Supplement_1","key":"10.1016\/j.diabres.2024.111983_b0485","first-page":"S111","article-title":"6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes\u20142024","volume":"47","author":"Committee","year":"2023","journal-title":"Diabetes Care"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822724008933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T11:29:00Z","timestamp":1738409340000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822724008933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":97,"alternative-id":["S0168822724008933"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111983","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing obesity in adults with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2024.111983","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111983"}}